About Aspire Pharma
Aspire Pharma is a company based in Petersfield (United Kingdom) founded in 2009 was acquired by Morningside Pharmaceuticals in October 2022. Aspire Pharma has completed 3 acquisitions, including Cenote Pharma, Morningside Healthcare and Morningside Pharmaceuticals.
- Headquarter Petersfield, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$101.09 M (USD)30as on Dec 31, 2022
-
Net Profit
$24.3 M (USD)-2as on Dec 31, 2023
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Morningside Pharmaceuticals
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Cenote Pharma
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aspire Pharma
Detailed funding history for Aspire Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aspire Pharma
Aspire Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Morningside Pharmaceuticals and H.I.G. Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity capital is invested in small and mid-sized businesses.
|
Locked | Locked | Locked | |
|
Healthcare products are distributed diversely across sectors by Morningside Pharmaceuticals.
|
Locked | Locked | Locked |
Investor details for Aspire Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aspire Pharma
Aspire Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cenote Pharma, Morningside Healthcare and Morningside Pharmaceuticals.
Investment portfolio details for Aspire Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Medicines for rare metabolic disorders are developed by Cenote Pharma.
|
Locked | Locked | 2015 | Locked | |
|
Provider of medicinal products supply chain and logistic services for pharmaceutical industry
|
Locked | Locked | 2001 | Locked | |
|
Healthcare products are distributed diversely across sectors by Morningside Pharmaceuticals.
|
Locked | Locked | 1991 | Locked |
Complete acquisition details for Aspire Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aspire Pharma
Detailed financials for Aspire Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aspire Pharma Comparisons
Peer comparison for Aspire Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aspire Pharma
Detailed competitors of Aspire Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aspire Pharma
Complete news archive for Aspire Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aspire Pharma
Aspire Pharma was founded in 2009.
Aspire Pharma is headquartered in Petersfield, United Kingdom. It is registered at Petersfield, Hampshire, United Kingdom.
Annual revenue of Aspire Pharma is $101.09M as on Dec 31, 2022.
Aspire Pharma was founded in 2009 as a British pharmaceutical company based in Petersfield, United Kingdom. Operations focus on in-licensing and commercializing therapeutic drugs and medical devices across categories such as anti-microbials, anti-fungals, proton pump inhibitors, anti-allergy treatments, cardiac medications, central nervous system and psychiatry products, and analgesics. The company serves the traditional pharma sector with a portfolio targeted at various therapeutic needs.
Aspire Pharma has made 3 acquisitions, including Cenote Pharma, Morningside Healthcare, and Morningside Pharmaceuticals.
Aspire Pharma has 2 investors. Key investors include Morningside Pharmaceuticals, and H.I.G. Capital.